Yi Zhou, Ying He, Xue Teng, Jing Mi, Jing Yang, Rongrui Wei, . . . Zhipei Sang. (2023). Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYi Zhou, et al. Development of Novel Salicylic Acid-donepezil-rivastigmine Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationYi Zhou, et al. Development of Novel Salicylic Acid-donepezil-rivastigmine Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.